BEYOND MEAT, INC. (NASDAQ: BYND) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Beyond Meat, Inc. Investors of Upcoming Deadline
globenewswire.com
Want to monitor DCTH?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor DCTHdelcath systems, inc. (nasdaq- dcth) is a specialty pharmaceutical and medical device company focused on the treatment of primary and metastatic liver cancers. our proprietary product---melphalan hydrochloride for injection for use with the delcath hepatic delivery system (melphalan/hds)---is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure.